ASX 200 Slips Yet Logs Monthly, Quarterly Gains

2026-06-30 06:41 By Farida Husna 1 min. read

The ASX 200 fell 45 points, or 0.5%, to close at 8,779 on Tuesday, snapping two sessions of gains as weakness in non-energy minerals, transport, and producer manufacturing weighed.

Sentiment turned cautious after the Reserve Bank of Australia's June meeting minutes flagged inflation still well above the 2–3% target, with underlying pressures seen mounting in Q2.

Policymakers signaled further tightening remains possible after three hikes this year, noting restrictive policy and elevated oil prices could temper demand and aid economic rebalancing.

Two of the big four banks slipped between 0.3% and 0.7%, while BHP Group (-0.9%), Northern Star (-5.2%), and Evolution (-4.7%) lagged.

In contrast, Euroz Hartleys jumped 7.6% after agreeing to sell its capital markets arm to Canada’s Bank of Montreal.

Despite the pullback, the market logged a third straight monthly gain, up by 0.5% and around 3.5% for the quarter, underpinned by resilient spending, stronger jobs, and continued factory growth.



News Stream
ASX 200 Slips Yet Logs Monthly, Quarterly Gains
The ASX 200 fell 45 points, or 0.5%, to close at 8,779 on Tuesday, snapping two sessions of gains as weakness in non-energy minerals, transport, and producer manufacturing weighed. Sentiment turned cautious after the Reserve Bank of Australia's June meeting minutes flagged inflation still well above the 2–3% target, with underlying pressures seen mounting in Q2. Policymakers signaled further tightening remains possible after three hikes this year, noting restrictive policy and elevated oil prices could temper demand and aid economic rebalancing. Two of the big four banks slipped between 0.3% and 0.7%, while BHP Group (-0.9%), Northern Star (-5.2%), and Evolution (-4.7%) lagged. In contrast, Euroz Hartleys jumped 7.6% after agreeing to sell its capital markets arm to Canada’s Bank of Montreal. Despite the pullback, the market logged a third straight monthly gain, up by 0.5% and around 3.5% for the quarter, underpinned by resilient spending, stronger jobs, and continued factory growth.
2026-06-30
Australian Stocks Subdued But Head for Monthly, Quarterly Gains
Australian shares were little changed, hovering near 8,823 in early Tuesday trade and pausing after two sessions of gains, as investors awaited the central bank’s June meeting minutes later today for clues on the policy outlook. Traders also turned to June PMI in China, with the data expected to shed light on demand from Australia’s largest trading partner. Meanwhile, U.S. futures eased after Wall Street posted strong gains overnight, with signs of de-escalation in U.S.–Iran tensions supporting broader risk sentiment. Gains in tech, consumer, and commercial services helped offset weakness in miners and energy. The big four banks rose 0.9%–1.4%, while Computershare (2.6%) and Pro Medicus (1.9%) advanced. However, heavyweight BHP Group (-0.7%) and Telstra (-1.4%) lagged. The ASX is up about 1% in June, set for a third straight monthly gain, supported by resilient spending and a rebound in employment. The benchmark is also tracking its first quarterly rise in three, up around 4% so far.
2026-06-30
ASX 200 Up 0.7% at Close
Australia’s ASX 200 rose 59 points, or 0.7%, to end at 8,823 on Monday, building strength from the prior session amid a sharp rise in U.S. stock futures as Washington and Tehran reportedly agreed to halt hostilities and resume peace talks. Sentiment was also lifted by strong growth in China’s industrial profits over the first five months of 2026, highlighting resilience in Australia’s key trading partner. However, caution emerged ahead of China’s June PMI data later this week, both from officials and a private survey. Meanwhile, the Reserve Bank’s June minutes will also be due, with investors wary that the central bank may retain its tightening bias to rein in inflation. Commercial services, consumer non-durables, and healthcare drove the gains. Strong iron ore prices supported BHP Group (1.4%) and Fortescue (2.4%). Ramelius Resources climbed 2.3% after agreeing to sell its Edna May Gold Hub. Neuren Pharmaceuticals surged 36.1% on EU approval for its Rett syndrome drug.
2026-06-29